EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PCIF1 Attenuates Type I Interferon Induction by Inhibiting IRF3 Activation in a Methyltransferase-Independent Manner

Ryoya Kano, Chihiro Oyama, Chihiro Ikeda, Akiko Inujima iD, Keiichi Koizumi iD, Shinichiro Akichika iD, Tsutomu Suzuki, Aki Tanaka, Yoshiaki Ohkuma, Yutaka Hirose

Cells · 2026

DOI: 10.3390/cells15030303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Ryoya Kano und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gene Regulation, Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. Hauptthemen laut MEDLINE: Interferon Regulatory Factor-3, Interferon Type I, Methyltransferases. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Japan Society for the Promotion of Science, the Ministry of Education, Culture, Sports, Science, and Technology, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PCIF1 is primarily recognized as an RNA methyltransferase that mediates N6-methylation of cap-proximal adenosine (m6Am) and plays diverse roles in gene expression. In this study, we uncover a novel role for PCIF1 as a crucial negative regulator of type I interferon (IFN) induction, a pathway critical for antiviral immunity whose dysregulation leads to inflammatory and autoimmune diseases. We demonstrate that PCIF1 deficiency robustly enhances the poly(I:C)-induced type I IFN response, accompanied by augmented STAT1 activation and interferon-stimulated gene (ISG) expression. Mechanistically, PCIF1 suppresses IFNB1 transcription by attenuating IRF3 phosphorylation and nuclear translocation, as shown by increased nascent IFNB1 mRNA synthesis and promoter activity in PCIF1-deficient cells, without affecting the mRNA stability. Crucially, this suppressive function was independent of PCIF1’s canonical RNA methyltransferase activity, as both wild-type PCIF1 and a methyltransferase-inactive mutant effectively attenuated type I IFN induction. Collectively, our findings establish PCIF1 as a novel methyltransferase-independent suppressor of type I IFN responses, revealing its previously unrecognized non-catalytic function. This discovery offers critical insights into the multifaceted regulation of innate immunity and highlights PCIF1’s non-catalytic function as a promising therapeutic target for modulating antiviral responses and inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon Regulatory Factor-3Interferon Type IMethyltransferasesHumansAnimalsMicePhosphorylationImmunity, InnateRNA, Messenger

Stichwörter der Autor:innen

IRF3PCIF1antiviral responseinnate immunitym6AmmRNA modificationstranscriptional regulationtype I interferon

Substanzen

Interferon Regulatory Factor-3Interferon Type IMethyltransferasesRNA, MessengerIRF3 protein, human

Autor:innen und Institutionen

  • Department of Gene Regulation, Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
  • Department of Medical Oncology, Kanazawa Medical University, 1-1 Daigaku, Uchinada-Machi, Kahoku 920-0293, Japan.
  • Division of Presymptomatic Disease, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan.
  • Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, Tokyo 113-8656, Japan.
  • Department of Biochemistry, Graduate School of Biomedical Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.

ORCID-Profile: Akiko Inujima, Keiichi Koizumi, Shinichiro Akichika

Förderung

  • the Japan Society for the Promotion of Science
  • the Ministry of Education, Culture, Sports, Science, and Technology
  • Japan Science and Technology Agency

Zitieren

APA

Kano, R., Oyama, C., Ikeda, C., Inujima, A., Koizumi, K., Akichika, S., Suzuki, T., Tanaka, A., Ohkuma, Y., & Hirose, Y. (2026). PCIF1 Attenuates Type I Interferon Induction by Inhibiting IRF3 Activation in a Methyltransferase-Independent Manner. Cells. https://doi.org/10.3390/cells15030303

Vancouver

Kano R, Oyama C, Ikeda C, Inujima A, Koizumi K, Akichika S, et al. PCIF1 Attenuates Type I Interferon Induction by Inhibiting IRF3 Activation in a Methyltransferase-Independent Manner. Cells. 2026. doi:10.3390/cells15030303

BibTeX
@article{Kano2026,
  author = {Kano, Ryoya and Oyama, Chihiro and Ikeda, Chihiro and Inujima, Akiko and Koizumi, Keiichi and Akichika, Shinichiro and Suzuki, Tsutomu and Tanaka, Aki and Ohkuma, Yoshiaki and Hirose, Yutaka},
  title = {PCIF1 Attenuates Type I Interferon Induction by Inhibiting IRF3 Activation in a Methyltransferase-Independent Manner},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15030303}
}
Kostenlos starten →